DOI: 10.1038/nbt1297-1318. Drug Development: The role of innovation in drug development

Drug Development: The role of innovation in drug development

10.1038/nbt1297-1318

Crossref journal-article

Springer Science and Business Media LLC

Nature Biotechnology (297)

Bibliography

Drews, J., & Ryser, S. (1997). Drug Development: The role of innovation in drug development. Nature Biotechnology, 15(13), 1318â1319.

Authors 2

Jürgen Drews (first)
Stefan Ryser (additional)

References 8 Referenced 136

Human disease—From genetic causes to biochemical effects. Proceedings of the Roche Symposium “The Genetic Basis of Human Disease”, October 2–3, 1996, Basel. Drews, J. and Ryser, S. (eds.) Ex Libris Roche 9. Blackwell Science, Berlin.
Lifton, R. Human disease—From genetic causes to biochemical effects. Proceedings of the Roche Symposium “The Genetic Basis of Human Disease”, October 2–3, 1996, Basel. Drews, J. and Ryser, S. (eds.) Ex Libris Roche 9. Blackwell Science, Berlin.
Weber, W. 1997. pp. 10–11 in Pharmacogenetics. Oxford Univ. Press, New York and Oxford. / Pharmacogenetics by W Weber (1997)
Ohsako, S. and Deguchi, T. 1990. J. Biol. Chem. 265: 4630–4634. (10.1016/S0021-9258(19)39609-7) / J. Biol. Chem. by S Ohsako (1990)
Weber, W. 1997. pp. 12–13 in Pharmacogenetics. Oxford Univ. Press, New York and Oxford. / Pharmacogenetics by W Weber (1997)
Mossinghoff, G.J. 1995. Drug Info. J. 29: 1077–1090. (10.1177/009286159502900403) / Drug Info. J. by GJ Mossinghoff (1995)
Drews, J. and Ryser, S. 1997. Drug Discovery Today 2: 365–372. (10.1016/S1359-6446(97)01086-6) / Drug Discovery Today by J Drews (1997)
It is obvious that these constraints are entirely dependent on a set of financial assumptions relating to costs, sales and discount rates for R&D expenditures. If these assumptions are modified, if for instance the discount rates after launch are lowered from 14% to 8% or if only out of pocket expenses are taken into account and opportunity costs altogether neglected, the picture brightens considerably. Eventually, such changes may have to be made.

Dates

Type	When
Created	21 years ago (Aug. 18, 2004, 6:38 p.m.)
Deposited	2 years, 3 months ago (May 18, 2023, 3:52 p.m.)
Indexed	2 months, 2 weeks ago (June 17, 2025, 8:04 a.m.)
Issued	27 years, 9 months ago (Dec. 1, 1997)
Published	27 years, 9 months ago (Dec. 1, 1997)
Published Print	27 years, 9 months ago (Dec. 1, 1997)

Funders 0

None

BibTeX

@article{Drews_1997, title={Drug Development: The role of innovation in drug development}, volume={15}, ISSN={1546-1696}, url={http://dx.doi.org/10.1038/nbt1297-1318}, DOI={10.1038/nbt1297-1318}, number={13}, journal={Nature Biotechnology}, publisher={Springer Science and Business Media LLC}, author={Drews, Jürgen and Ryser, Stefan}, year={1997}, month=dec, pages={1318–1319} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        6,
        17
      ]
    ],
    "date-time": "2025-06-17T12:04:16Z",
    "timestamp": 1750161856733
  },
  "reference-count": 8,
  "publisher": "Springer Science and Business Media LLC",
  "issue": "13",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1997,
            12,
            1
          ]
        ],
        "date-time": "1997-12-01T00:00:00Z",
        "timestamp": 880934400000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "http://www.springer.com/tdm"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1997,
        12
      ]
    ]
  },
  "DOI": "10.1038/nbt1297-1318",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2004,
        8,
        18
      ]
    ],
    "date-time": "2004-08-18T22:38:40Z",
    "timestamp": 1092868720000
  },
  "page": "1318-1319",
  "source": "Crossref",
  "is-referenced-by-count": 136,
  "title": "Drug Development: The role of innovation in drug development",
  "prefix": "10.1038",
  "volume": "15",
  "author": [
    {
      "given": "J\u00fcrgen",
      "family": "Drews",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Stefan",
      "family": "Ryser",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "reference": [
    {
      "key": "BFnbt12971318_CR1",
      "unstructured": "Human disease\u2014From genetic causes to biochemical effects. Proceedings of the Roche Symposium \u201cThe Genetic Basis of Human Disease\u201d, October 2\u20133, 1996, Basel. Drews, J. and Ryser, S. (eds.) Ex Libris Roche 9. Blackwell Science, Berlin."
    },
    {
      "key": "BFnbt12971318_CR2",
      "unstructured": "Lifton, R. Human disease\u2014From genetic causes to biochemical effects. Proceedings of the Roche Symposium \u201cThe Genetic Basis of Human Disease\u201d, October 2\u20133, 1996, Basel. Drews, J. and Ryser, S. (eds.) Ex Libris Roche 9. Blackwell Science, Berlin."
    },
    {
      "key": "BFnbt12971318_CR3",
      "first-page": "10",
      "volume-title": "Pharmacogenetics",
      "author": "W Weber",
      "year": "1997",
      "unstructured": "Weber, W. 1997. pp. 10\u201311 in Pharmacogenetics. Oxford Univ. Press, New York and Oxford."
    },
    {
      "key": "BFnbt12971318_CR4",
      "doi-asserted-by": "crossref",
      "first-page": "4630",
      "DOI": "10.1016/S0021-9258(19)39609-7",
      "volume": "265",
      "author": "S Ohsako",
      "year": "1990",
      "unstructured": "Ohsako, S. and Deguchi, T. 1990. J. Biol. Chem. 265: 4630\u20134634.",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "BFnbt12971318_CR5",
      "first-page": "12",
      "volume-title": "Pharmacogenetics",
      "author": "W Weber",
      "year": "1997",
      "unstructured": "Weber, W. 1997. pp. 12\u201313 in Pharmacogenetics. Oxford Univ. Press, New York and Oxford."
    },
    {
      "key": "BFnbt12971318_CR6",
      "doi-asserted-by": "publisher",
      "first-page": "1077",
      "DOI": "10.1177/009286159502900403",
      "volume": "29",
      "author": "GJ Mossinghoff",
      "year": "1995",
      "unstructured": "Mossinghoff, G.J. 1995. Drug Info. J. 29: 1077\u20131090.",
      "journal-title": "Drug Info. J."
    },
    {
      "key": "BFnbt12971318_CR7",
      "doi-asserted-by": "publisher",
      "first-page": "365",
      "DOI": "10.1016/S1359-6446(97)01086-6",
      "volume": "2",
      "author": "J Drews",
      "year": "1997",
      "unstructured": "Drews, J. and Ryser, S. 1997. Drug Discovery Today 2: 365\u2013372.",
      "journal-title": "Drug Discovery Today"
    },
    {
      "key": "BFnbt12971318_CR8",
      "unstructured": "It is obvious that these constraints are entirely dependent on a set of financial assumptions relating to costs, sales and discount rates for R&D expenditures. If these assumptions are modified, if for instance the discount rates after launch are lowered from 14% to 8% or if only out of pocket expenses are taken into account and opportunity costs altogether neglected, the picture brightens considerably. Eventually, such changes may have to be made."
    }
  ],
  "container-title": "Nature Biotechnology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://www.nature.com/articles/nbt1297-1318",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/nbt1297-1318.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/nbt1297-1318.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T19:52:30Z",
    "timestamp": 1684439550000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/nbt1297-1318"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1997,
        12
      ]
    ]
  },
  "references-count": 8,
  "journal-issue": {
    "issue": "13",
    "published-print": {
      "date-parts": [
        [
          1997,
          12
        ]
      ]
    }
  },
  "alternative-id": [
    "BFnbt12971318"
  ],
  "URL": "http://dx.doi.org/10.1038/nbt1297-1318",
  "relation": {},
  "ISSN": [
    "1087-0156",
    "1546-1696"
  ],
  "subject": [],
  "container-title-short": "Nat Biotechnol",
  "published": {
    "date-parts": [
      [
        1997,
        12
      ]
    ]
  }
}